Administration of MELPIDA to Determine the Safety and Efficacy for Patients With Spastic Paraplegia Type 50

NCT06069687 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Spastic Paraplegia Type 50

Interventions

BIOLOGICAL: MELPIDA

Sponsor

The Hospital for Sick Children